• Something wrong with this record ?

Upregulation of genes involved in cardiac metabolism enhances myocardial resistance to ischemia/reperfusion in the rat heart

T. Ravingerová, S. Čarnická, V. Ledvényiová, E. Barlaka, E. Galatou, A. Chytilová, P. Mandíková, M. Nemčeková, A. Adameová, F. Kolář, A. Lazou

. 2013 ; 62 (Suppl. 1) : S151-S163.
. 2013 ; 62 (Suppl. 1) : S151-S163.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14070282

UNLABELLED: Genes encoding enzymes involved in fatty acids (FA) and glucose oxidation are transcriptionally regulated by peroxisome proliferator-activated receptors (PPAR), members of the nuclear receptor superfamily. Under conditions associated with O(2) deficiency, PPAR-alpha modulates substrate switch (between FA and glucose) aimed at the adequate energy production to maintain basic cardiac function. Both, positive and negative effects of PPAR-alpha activation on myocardial ischemia/reperfusion (I/R) injury have been reported. Moreover, the role of PPAR-mediated metabolic shifts in cardioprotective mechanisms of preconditioning (PC) is relatively less investigated. We explored the effects of PPAR-alpha upregulation mimicking a delayed "second window" of PC on I/R injury in the rat heart and potential downstream mechanisms involved. Pretreatment of rats with PPAR-alpha agonist WY-14643 (WY, 1 mg/kg, i.p.) 24 h prior to I/R reduced post-ischemic stunning, arrhythmias and the extent of lethal injury (infarct size) and apoptosis (caspase-3 expression) in isolated hearts exposed to 30-min global ischemia and 2-h reperfusion. Protection was associated with remarkably increased expression of PPAR-alpha target genes promoting FA utilization (medium-chain acyl-CoA dehydrogenase, pyruvate dehydrogenase kinase-4 and carnitine palmitoyltransferase I) and reduced expression of glucose transporter GLUT-4 responsible for glucose transport and metabolism. In addition, enhanced Akt phosphorylation and protein levels of eNOS, in conjunction with blunting of cardioprotection by NOS inhibitor L-NAME, were observed in the WY-treated hearts. CONCLUSIONS: upregulation of PPAR-alpha target metabolic genes involved in FA oxidation may underlie a delayed phase PC-like protection in the rat heart. Potential non-genomic effects of PPAR-alpha-mediated cardioprotection may involve activation of prosurvival PI3K/Akt pathway and its downstream targets such as eNOS and subsequently reduced apoptosis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14070282
003      
CZ-PrNML
005      
20151006144016.0
007      
ta
008      
140904s2013 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932597 $2 doi
035    __
$a (PubMed)24329695
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ravingerová, Táňa, $d 1951- $7 xx0248557 $u Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence of SAS NOREG, Bratislava, Slovak Republic
245    10
$a Upregulation of genes involved in cardiac metabolism enhances myocardial resistance to ischemia/reperfusion in the rat heart / $c T. Ravingerová, S. Čarnická, V. Ledvényiová, E. Barlaka, E. Galatou, A. Chytilová, P. Mandíková, M. Nemčeková, A. Adameová, F. Kolář, A. Lazou
520    9_
$a UNLABELLED: Genes encoding enzymes involved in fatty acids (FA) and glucose oxidation are transcriptionally regulated by peroxisome proliferator-activated receptors (PPAR), members of the nuclear receptor superfamily. Under conditions associated with O(2) deficiency, PPAR-alpha modulates substrate switch (between FA and glucose) aimed at the adequate energy production to maintain basic cardiac function. Both, positive and negative effects of PPAR-alpha activation on myocardial ischemia/reperfusion (I/R) injury have been reported. Moreover, the role of PPAR-mediated metabolic shifts in cardioprotective mechanisms of preconditioning (PC) is relatively less investigated. We explored the effects of PPAR-alpha upregulation mimicking a delayed "second window" of PC on I/R injury in the rat heart and potential downstream mechanisms involved. Pretreatment of rats with PPAR-alpha agonist WY-14643 (WY, 1 mg/kg, i.p.) 24 h prior to I/R reduced post-ischemic stunning, arrhythmias and the extent of lethal injury (infarct size) and apoptosis (caspase-3 expression) in isolated hearts exposed to 30-min global ischemia and 2-h reperfusion. Protection was associated with remarkably increased expression of PPAR-alpha target genes promoting FA utilization (medium-chain acyl-CoA dehydrogenase, pyruvate dehydrogenase kinase-4 and carnitine palmitoyltransferase I) and reduced expression of glucose transporter GLUT-4 responsible for glucose transport and metabolism. In addition, enhanced Akt phosphorylation and protein levels of eNOS, in conjunction with blunting of cardioprotection by NOS inhibitor L-NAME, were observed in the WY-treated hearts. CONCLUSIONS: upregulation of PPAR-alpha target metabolic genes involved in FA oxidation may underlie a delayed phase PC-like protection in the rat heart. Potential non-genomic effects of PPAR-alpha-mediated cardioprotection may involve activation of prosurvival PI3K/Akt pathway and its downstream targets such as eNOS and subsequently reduced apoptosis.
650    _2
$a zvířata $7 D000818
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a reperfuzní poškození myokardu $x metabolismus $x prevence a kontrola $7 D015428
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a PPAR alfa $x metabolismus $7 D047493
650    _2
$a pyrimidiny $x terapeutické užití $7 D011743
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a obnova funkce $7 D020127
650    _2
$a výsledek terapie $7 D016896
650    _2
$a upregulace $x účinky léků $7 D015854
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Čarnická, Slávka $7 xx0146449 $u Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence of SAS NOREG, Bratislava, Slovak Republic
700    1_
$a Ledvényiová, V. $7 _AN070794 $u Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence of SAS NOREG, Bratislava, Slovak Republic,
700    1_
$a Barlaka, E. $u School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
700    1_
$a Galatou, E. $u School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
700    1_
$a Chytilová, Anna. $7 xx0239932 $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Mandíková, P. $7 _AN079685 $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Nemčeková, Mária, $d 1947- $7 xx0079036 $u Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence of SAS NOREG, Bratislava, Slovak Republic
700    1_
$a Adameová, Adriana $7 xx0064778 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovak Republic
700    1_
$a Kolář, František, $d 1952 říjen 2.- $7 xx0037264 $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Lazou, A. $u School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 62,Suppl. 1 (2013), s. S151-S163
773    0_
$t Proceedings of the ... Physiological days $x 1802-9973 $g Roč. 62,Suppl. 1 (2013), s. S151-S163 $w MED00183838
856    41
$u http://www.biomed.cas.cz/physiolres/2013/S1_13.htm $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20140904 $b ABA008
991    __
$a 20151006144201 $b ABA008
999    __
$a ok $b bmc $g 1038456 $s 869135
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 62 $c Suppl. 1 $d S151-S163 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2013 $b 62 $c Suppl. 1 $d S151-S163 $i 1802-9973 $m Proceedings of the ... Physiological days $n $x MED00183838
LZP    __
$b NLK118 $a Pubmed-20140904

Find record

Citation metrics

Archiving options